Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-05-31
2005-05-31
Smith, Lynette R. F. (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C530S403000, C530S388100, C424S193100, C435S006120, C435S005000, C435S007200, C435S007100, C435S007910, C435S007920
Reexamination Certificate
active
06900291
ABSTRACT:
The present invention relates to methods and materials for the detection and quantitation 8-OH-Ade in biological specimens. Specifically, the present invention is directed to a group of highly specific monoclonal antibodies reactive with the modified nucleoside structure 8-OH-Ade, and to various immunoassays for 8-OH-Ade utilizing these monoclonal antibodies. The monoclonal antibodies of the present invention may be used in assays for diagnosing or monitoring the progression of certain types of cancer, in addition to a variety of other diseases associated with mutagenesis resulting from oxidative damage of DNA. Assays utilizing the monoclonal antibodies of the present invention may also be used to analyze or monitor toxicant exposure, such as from environmental sources. The monoclonal antibodies of the present invention were prepared with the immunogen 8-OH-adenosine coupled to keyhole limpet hemocyanin (KLH), not to 8-OH-Ade directly. It is believed that the monoclonal antibodies bind with the base portion of the structure (8-OH-Ade) and not the carbohydrate (ribose) or protein linkage region of the conjugate, because, as demonstrated, conjugates bound to nucleosides other than 8-OH-adenosine were unreactive with these antibodies. Therefore, the antibodies of the present invention can be used to detect and quantitate (by the use of a standard curve) the presence of 8-OH-Ade in biological specimens of DNA. Procedures for such an assay include immobilizing the DNA, denaturing it to disrupt the base-pairing scheme exposing the free base structures, and quantitating the amount of 8-OH-Ade present per amount of DAN in a quantitative immunoassay.
REFERENCES:
patent: 4017597 (1977-04-01), Reynolds
patent: 4478934 (1984-10-01), Sato et al.
patent: 4701323 (1987-10-01), Roth et al.
patent: 4824941 (1989-04-01), Gordon et al.
patent: 4833084 (1989-05-01), Carrico
patent: 4923813 (1990-05-01), Hecht et al.
patent: 5552285 (1996-09-01), Frenkel
patent: 5601981 (1997-02-01), Malins
patent: 5605795 (1997-02-01), Bronstein
patent: 5665553 (1997-09-01), Malins
patent: 5721341 (1998-02-01), Molko et al.
patent: 5827645 (1998-10-01), Sundrehagen
patent: 6063581 (2000-05-01), Sundrehagen
patent: 6187551 (2001-02-01), Holmes et al.
patent: 3-65650 (1991-02-01), None
patent: 3065650 (1991-03-01), None
patent: WO 92/15707 (1992-09-01), None
patent: WO 93/12258 (1993-06-01), None
patent: 93/12258 (1993-06-01), None
patent: 94/25626 (1994-11-01), None
patent: WO 95/07907 (1995-03-01), None
patent: 95/07907 (1995-03-01), None
patent: WO 96/38588 (1996-12-01), None
Nicolas, M et al, Ann. Inst. Pasteur/Immunol. 1987, vol. 138, pp. 83-96 “Enzyme Immunoassay fo 2′5' oligoadenylates at the femtomole level.” .*
Batova, IN et al, Biochemistry and molecular biology international (Australia) Mar. 1993, vol. 29(3), “Base specificity and binding of anti-ss/dsDNA monoclonal antibody Application to the determination of ssDNA” pp. 451-466.*
Johnston, MI et al, Biochemistry, Aug. 13, 1985, vol. 24(17), pp. 4710-4708.*
Cailla, H et al, PNAS, Aug. 1982, vol. 79(15) pp. 4762-4766.*
Adamkiewicz, J., et al., “Monoclonal Antibody-Based Immunoanalytical Methods for Detection of Carcinogen-Modified DNA Components,”IARC Sci. Publ. 70:403-411, 1986.
Bhimani, R.S., et al., “Inhibition of Oxidative Stress in HeLa Cells by Chemopreventive Agents,”Cancer Research 53:4528-4533, Oct. 1, 1993.
Catty, D., and C. Raykundalia, “ELISA and Related Enzyme Immunoassays,” in D. Catty (ed.),Antibodies: volume II: A Practical Approach, IRL Press at Oxford University Press, Oxford, England, 1989, pp. 97-154.
Cho, B.P., and F.E. Evans, “Structure of Oxidatively Damaged Nucleic Acid Adducts. 3. Tautomerism, Ionization and Protonation of 8-Hydroxyadenosine Studied by15N NMR Spectroscopy,”Nucleic Acids Research 19(5):1041-1047, 1991.
Degan, P., et al., “Immunoaffinity Isolation of Urinary 8-Hydroxy- 2′-Deoxyguanosine and 8-Hydroxyguanine and Quantitation of 8-Hydroxy- 2′-Deoxyguanosine in DNA by Polyclonal Antibodies,”Carcinogenesis 12(5):865-871, May 1991.
Dreher, D., and A.F. Junod, “Role of Oxygen Free Radicals in Cancer Development,”European Journal of Cancer 32A(1):30-38, 1996.
Halliwell, B., “Free Radicals, Antioxidants, and Human Disease: Curiosity, Cause, or Consequence?”The Lancet 344:721-724, Sep. 10, 1994.
Halliwell, B., and M. Dizdaroglu, “Commentary: The Measurement of Oxidative Damage to DNA by HPLC and GC/MS Techniques,”Free Rad Res. Comms. 16(2):75-87, 1992.
Hussain, S.P., et al., “Oxy-Radical Induced Mutagenesis of Hotspot Codons 248 and 249 of the Human p53 Gene,”Oncogene 9:2277-2281, 1994.
Ide, H., et al., “Immunochemical Measurement of 8-Hydroxypurines in X-Irradiated DNA,” Abstracts, 19th Annual Meetings, UCLA Symposia on Molecular & Cellular Biology,Journal of Cellular Biochemistry, Supplement 14A, Jan. 13-28, 1990.
Ide, H., et al., “Antibodies to Oxidative DNA Damage: Characterization of Antibodies to 8-Oxopurines,”Cell Biology and Toxicology 13:405-417, 1997.
Inagake, M., et al., “Inhibition of 1,2-Dimethylhydrazine-Induced Oxidative DNA Damage by Green Tea Extract in Rat,”Jpn. J. Cancer Res. 86:1106-1111, Nov. 1995.
Lee, Y.-S., et al., “Identification of 8-Hydroxyguanine Glycosylase Activity in Mammalian Tissues Using 8-Hydroxyguanine Specific Monoclonal Antibody,”Biochemical and Biophysical Research Communications, 196(3):l545-1551, Nov. 15, 1993.
Loft, S., and H.E. Poulsen, “Cancer Risk and Oxidative DNA Damage in Man,”J. Mol. Med. 74:297-312, 1996.
MacCubbin, A.E., et al., “32P-Postlabeling Assay for Free Radical-Induced DNA Damage: The Formamido Remnant of Thymine,”Free Rad. Res. Comms. 18(1):17-28, 1993.
Malins, D.C., and R. Haimanot, “4,6-Diamino-5-Formamidopyrimidine, 8-Hydroxyguanine and 8-Hydroxyadenine in DNA From Neoplastic Liver of English Sole Exposed to Carcinogens,”Biochemical and Biophysical Research Communications 173(2):614-619, Dec. 14, 1990.
Malins, D.C., et al., “The Etiology of Breast Cancer,”Cancer 71(10):3036-3043, May 15, 1993.
Masuda, M., et al., “An Immunohistochemical Analysis for Cancer of the Esophagus Using Monoclonal Antibodies Specific for Modified Nucleosides,”Cancer 72(12):3571-3578, Dec. 15, 1993.
Musarrat, J., and A.A. Wani, “Quantitative Immunoanalysis of Promutagenic 8-Hydroxy-2′-Deoxyguanosine in Oxidized DNA,”Carcinogenesis 15(9):2037-2043, 1994.
Musarrat, J., et al., “Prognostic and Aetiological Relevance of 8-Hydroxyguanosine in Human Breast Carcinogenesis,”European Journal of Cancer 32A(7):1209-1214, 1996.
Nagashima, M., et al., “8-Hydroxydeoxyguanosine Levels in DNA of Human Breast Cancers Are Not Significantly Different From Those of Non-Cancerous Breast Tissues by the HPLC-ECD Method,”Cancer Letters 90:157-162, 1995.
Park, E.-M., et al., “Assay of Excised Oxidative DNA Lesions: Isolation of 8- Oxoguanine and Its Nucleoside Derivatives From Biological Fluids With a Monoclonal Antibody Column,”Proc. Natl. Acad Sci. USA 89:3375-3379, Apr. 1992.
Park, J.-W., et al., “Detection of DNA Adducts by High-Performance Liquid Chromatography With Electrochemical Detection,”Carcinogenesis 10(5):827-832, 1989.
Shigenaga, M.K., and B.N. Ames, “Assays for 8-Hydroxy-2′-Deoxyguanosine: A Biomarker of In Vivo Oxidative DNA Damage,”Free Radical Biology&Medicine 10:211-216, 1991.
Shigenaga, M.K., et al., “Urinary 8-Hydroxy-2′-Deoxyguanosine as a Biological Marker of In Vivo Oxidative DNA Damage,”Proc. Natl. Acad. Sci. USA 86:9697-9701, Dec. 1989.
Shigenaga, M.K., et al, “In Vivo Oxidative DNA Damage: Measurement of 8-Hydroxy-2′-Deoxyguanosine in DNA and Urine by High-Performance Liquid Chromatography With Electrochemical Detection,”Methods in Enzymology
Greene Thomas G.
Holmes Eric H.
Christensen O'Connor Johnson & Kindness PLLC
CytoChem, Inc.
Portner Ginny Allen
Smith Lynette R. F.
LandOfFree
Detection and quantitation of 8-OH-adenine using monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection and quantitation of 8-OH-adenine using monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and quantitation of 8-OH-adenine using monoclonal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3450012